Article: Nicotinamide Riboside and CoQ10 Supplementation May Support Kidney Health in Chronic Kidney Disease: Clinical Findings

May 9, 2023 Clinical Kidney Disease Metabolic Health

Nicotinamide Riboside and CoQ10 Supplementation May Support Kidney Health in Chronic Kidney Disease: Clinical Findings

Objectives

To examine the effects of NR and coenzyme Q10 (CoQ10) supplementation alone for six weeks on physical endurance, work efficiency, and metabolic profile in chronic kidney disease (CKD) patients.

Journal

JCI Insight

Key Outcomes

NR supplementation showed a trend towards improved energy metabolism and submaximal exercise efficiency, suggesting better carbohydrate utilization for energy.
NR decreased plasma levels of NAD-dependent citric acid cycle intermediates, suggesting improved mitochondrial metabolism.
NR reduced short and medium-chained plasma triglycerides with a high degree of saturation (tightly packed), suggesting favorable changes in lipid metabolism.
CoQ10 reduced certain types of triglycerides and increased plasma free fatty acids.

Duration

6 weeks

Dose

1000 mg*
*Patients were given NR (1000 mg) or CoQ10 (1200 mg).

Study Design

Randomized double-blind, placebo-controlled, crossover study in 25 chronic kidney disease (CKD) patients

See Published Study

Clinical

Nicotinamide Riboside Supplementation May Influence Bacterial Composition: Clinical Findings

Objectives To explore the effects of NR supplementation on the gut microbiota composition in humans. Journal npj Aging Key Outcomes NR supplementation did not affect the diversity or abundance of...

Autoimmune Disease

Nicotinamide Riboside Supplementation Reduces Inflammatory Markers in Immune Cells from Healthy Subjects and Psoriasis Patients: Clinical Findings

Objectives To examine how ex-vivo NR supplementation affects adaptive immunity in CD4+ T cells extracted from healthy subjects and those with mild-moderate psoriasis, and to investigate the in viv...